Page last updated: 2024-09-03

imatinib mesylate and Neoplasms, Plasma Cell

imatinib mesylate has been researched along with Neoplasms, Plasma Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gupta, S; Janz, S; Lee, JS; Mushinski, JF; Owens, JD; Park, ES; Potter, M; Shaughnessy, JD; Wang, H; Woo, HG; Zhan, F	1

Reviews

1 review(s) available for imatinib mesylate and Neoplasms, Plasma Cell

Article	Year
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia. BMC genomics, 2007, Aug-31, Volume: 8 Topics: Animals; Benzamides; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, abl; Genes, myc; Humans; Imatinib Mesylate; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Models, Biological; Multiple Myeloma; Neoplasms, Plasma Cell; Piperazines; Pyrimidines; Signal Transduction; STAT Transcription Factors	2007

Article

Year

Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.

BMC genomics, 2007, Aug-31, Volume: 8

Topics: Animals; Benzamides; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, abl; Genes, myc; Humans; Imatinib Mesylate; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Models, Biological; Multiple Myeloma; Neoplasms, Plasma Cell; Piperazines; Pyrimidines; Signal Transduction; STAT Transcription Factors

2007